Bg pattern

ENTERO SILICONE 9 mg/ml ORAL EMULSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ENTERO SILICONE 9 mg/ml ORAL EMULSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el usuario

Entero-Silicona 9 mg/ml emulsión oral

Simeticona

Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento, porque contiene información importante para usted.

Siga exactamente las instrucciones de administración del medicamento contenidas en este prospecto o las indicadas por su médico o farmacéutico.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si necesita consejo o más información, consulte a su farmacéutico.
  • Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.
  • Debe consultar a un médico si empeora o si no mejora después de 10 días.

Contenido del prospecto

  1. Qué es Entero-Silicona y para qué se utiliza
  2. Qué necesita saber antes de empezar a tomar usar Entero-Silicona
  3. Cómo tomar Entero-Silicona
  4. Posibles efectos adversos
  5. Conservación de Entero-Silicona
  6. Contenido del envase e información adicional

1. Qué es Entero-Silicona y para qué se utiliza

El principio activo de Entero-Silicona es la simeticona, el cual pertenece a un grupo de medicamentos que actúan en el intestino destruyendo las burbujas de gas, facilitando su eliminación y aliviando las molestias que ocasionan.

Está indicado para el alivio sintomático de los gases en adultos, niños y lactantes.

Debe consultar a un médico si empeora o si no mejora después de 10 días.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a tomar Entero-Silicona

No tome Entero-Silicona:

Si es alérgico a la simeticona o a cualquiera de los demás componentes de este medicamento (incluidos en la sección 6).

Perforación y obstrucción intestinal conocida o sospechada.

Advertencias y precauciones:

Consulte a su médico o farmacéutico antes de empezar a tomar Entero-Silicona.

Si los síntomas empeoran o persisten, o en caso de estreñimiento prolongado, consulte con su médico.

Niños:

La simeticona no está recomendada para el tratamiento de los cólicos del lactante debido a la limitada información disponible.

Toma de Entero-Silicona con otros medicamentos:

Informe a su médico o farmacéutico si está utilizando, ha utilizado recientemente o podría tener que tomar cualquier otro medicamento.

Uso de Entero-Silicona con los alimentos y bebidas:

No tiene efectos conocidos de interacción con alimentos o bebidas. Utilizar preferentemente después de las comidas.

Embarazo y lactancia:

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.

Conducción y uso de máquinas:

Entero-Silicona no tiene efectos conocidos sobre la capacidad para conducir o utilizar máquinas.

Entero-Silicona contieneparahidroxibenzoato de metilo y etanol al 96 por ciento:

Puede producir reacciones alérgicas (posiblemente retardadas) porque contiene parahidroxibenzoato de metilo.

Este medicamento contiene 0,04% (v/v) de etanol al 96 por ciento (alcohol), esta pequeña cantidad se corresponde con 0,3 mg/ml.

3. Cómo tomar Entero-Silicona

Siga exactamente las instrucciones de administración del medicamento contenidas en este prospecto o las indicadas por su médico o farmacéutico. En caso de duda pregunte a su médico o farmacéutico.

La dosis recomendada en adultos y niños mayores de 12 años es:

10 ml ó 1 cucharada grande (90 mg de Simeticona) 3 veces al día. No administrar más de 55 ml ó 5 cucharadas y media cucharada grandes (495 mg de simeticona) al día.

Uso en niños:

Niños de 0 a 2 años:

La dosis recomendada es de 2,5 ml ó ½ cucharadita (22,5 mg de simeticona) 3 veces al día administrados con el biberón o con otro alimento o líquido. No administrar más de 25 ml ó 5 cucharaditas (225 mg de simeticona) al día.

Niños de 2 a 12 años:

La dosis recomendada es de 5 ml ó 1 cucharadita (45 mg de simeticona) 3 veces al día.

No administrar más de 25 ml ó 5 cucharaditas (225 mg de simeticona) al día.

Entero-Silicona se administra por vía oral después de las comidas.

Agitar el frasco antes de su utilización.

Si toma más Entero-Silicona del que debe:

No se conocen casos de sobredosificación.

Aún en el caso de que se ingiera una cantidad muy superior a la indicada, es muy poco probable que se produzcan efectos adversos, debido a la falta de absorción digestiva del fármaco.

En caso de sobredosis o ingestión accidental, consulte inmediatamente a su médico o farmacéutico o llame al Servicio de Información Toxicológica, teléfono: 91 562 04 20, indicando el medicamento y la cantidad ingerida.

Si olvidó tomar Entero-Silicona:

No tome una dosis doble para compensar las dosis olvidadas.

Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, Entero-Silicona puede producir efectos adversos, aunque no todas las personas los sufran.

Se han informado de las siguientes reacciones adversas con una frecuencia no conocida (no puede estimarse a partir de los datos disponibles):

  • Náuseas y estreñimiento.
  • Reacciones de hipersensibilidad, tales como erupción cutánea, picor, edema de la cara o de la lengua, dificultad respiratoria.

Comunicación de efectos adversos:

Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico, incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano, página Web: http.//www.notificaram.es.

Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Entero-Silicona

Mantener este medicamento fuera de la vista y del alcance de los niños.

No requiere condiciones especiales de conservación.

No utilice Entero-Silicona después de la fecha de caducidad que aparece en el envase después de CAD. La fecha de caducidad es el último día del mes que se indica.

Los medicamentos no se deben tirar por los desagües ni a la basura. Deposite los envases y los medicamentos que no necesita en el Punto SIGRE de la farmacia. En caso de duda pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que no necesita. De esta forma, ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición de Entero-Silicona:

  • El principio activo es la simeticona. Cada ml de emulsión oral contiene 9 mg de simeticona.
  • Los demás componentes son: carmelosa sódica (E-466), sacarina sódica (E-954), parahidroxibenzoato de metilo (E-218), alcohol polivinílico, esencia de anís (etanol al 96 por ciento y propilenglicol) y agua purificada. Ver sección 2 “Entero Silicona contiene parahidroxibenzoato de metilo y etanol al 96 por ciento”.

Aspecto del producto y contenido del envase:

Entero-Silicona se presenta en un frasco de 250 ml de emulsión oral.

La emulsión oral es un líquido opaco de color blanco que puede presentar separación de fases pero que al agitar se homogeneíza.

Titular de la autorización de comercialización y responsable de la fabricación:

LABORATORIO ESTEDI S.L.

Leopoldo Alas 7-Montseny 41

08012 Barcelona (España)

Representante local:

LABORATORIO ALDO-UNION S.L.

Baronesa de Maldà, 73

08950 Esplugues de Llobregat

Barcelona (España)

Este prospecto ha sido aprobado en {Mes/año}: Octubre/2013

La información detallada y actualizada de este medicamento está disponble en la página Web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) http://www.aemps.gob.es/.

Online doctors for ENTERO SILICONE 9 mg/ml ORAL EMULSION

Discuss questions about ENTERO SILICONE 9 mg/ml ORAL EMULSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ENTERO SILICONE 9 mg/ml ORAL EMULSION?
ENTERO SILICONE 9 mg/ml ORAL EMULSION does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ENTERO SILICONE 9 mg/ml ORAL EMULSION?
The active ingredient in ENTERO SILICONE 9 mg/ml ORAL EMULSION is silicones. This information helps identify medicines with the same composition but different brand names.
Who manufactures ENTERO SILICONE 9 mg/ml ORAL EMULSION?
ENTERO SILICONE 9 mg/ml ORAL EMULSION is manufactured by Laboratorio Estedi S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ENTERO SILICONE 9 mg/ml ORAL EMULSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ENTERO SILICONE 9 mg/ml ORAL EMULSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ENTERO SILICONE 9 mg/ml ORAL EMULSION?
Other medicines with the same active substance (silicones) include AERO RED 40 mg CHEWABLE TABLETS, AERO-RED 120 mg CHEWABLE TABLETS, AERO-RED FORTE 240 mg SOFT CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media